A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetesFirst published 15/07/2024 Last updated 15/07/2024 EU PAS number: EUPAS1000000260StudyFinalised